What antibiotic to use in this case
Citrobacter freundii urinary tract infection colistin treatment
| Antibiotic | Result |
|---|---|
| Colistin Sulphate | I (Intermediate), MIC ≤1 µg/mL |
| Amikacin | R |
| Amoxicillin | R |
| Amoxicillin+Clavulanic Acid | R |
| Ampicillin+Sulbactam | R |
| Aztreonam | R |
| Cefepime | R |
| Cefixime | R |
| Ceftazidime | R |
| Ceftazidime+Avibactam | R |
| Ceftriaxone | R |
| Ciprofloxacin | R |
| Co-trimoxazole | R |
| Doxycycline | R |
| Gentamicin | R |
| Imipenem | R |
| Levofloxacin | R |
| Meropenem | R |
| Piperacillin+Tazobactam | R |
The patient doesn’t have fever. He is under suprapubic catheterization
catheter associated bacteriuria asymptomatic treatment antibiotics
"The presence of asymptomatic bacteriuria often leads to improper antimicrobial treatment in patients with indwelling urinary catheters. Apart from pregnant patients, most others need not undergo urine culture or treatment for asymptomatic bacteriuria."
"Antibiotic treatment of asymptomatic bacteriuria in a patient with a short-term indwelling urinary catheter is not recommended, unless the patient is pregnant or a urologic procedure is immediately pending."
| Action | Rationale |
|---|---|
| Do NOT prescribe antibiotics | No symptomatic infection to treat; treatment drives resistance |
| Assess whether the catheter is still needed | Catheter removal is the most effective intervention |
| If catheter in place >14 days, replace it | Removes the biofilm reservoir; may clear bacteriuria |
| Repeat culture only if symptoms develop | Fever, rigors, flank pain, hematuria, pelvic pain |
| Do NOT reculture to confirm clearance | This perpetuates the "treat-reculture-escalate" cycle |
The patient is diagnosed with psychosis NOS and has frank pus in catheter
colistin fosfomycin XDR catheter UTI treatment
colistin fosfomycin combination multidrug resistant gram negative UTI
colistin urinary tract infection extensively drug resistant Citrobacter
| Agent to Test | Why |
|---|---|
| Fosfomycin | Concentrated in urine, often active against XDR gram-negatives, oral option |
| Nitrofurantoin | Active against some resistant organisms in lower UTI |
| Tigecycline | Broad XDR coverage (though poor urinary levels - less useful here) |
| Polymyxin B | Cross-checks colistin activity |
| Parameter | Detail |
|---|---|
| Drug | Colistimethate sodium (CMS) IV |
| Loading dose | 300 mg CBA (colistin base activity) as a single loading dose |
| Maintenance dose | 2.5-5 mg/kg/day CBA in 2-3 divided doses, adjusted to renal function |
| Duration | 7-14 days for complicated catheter-associated UTI |
| Monitoring | Serum creatinine daily, urine output, neurotoxicity signs |
Critical note on "Intermediate" MIC: The colistin MIC was ≤1 µg/mL. For urinary infections, colistin achieves urine concentrations of 25-200 µg/mL after IV dosing - far exceeding the MIC. What appears "intermediate" systemically is effectively susceptible in the urinary tract. This makes colistin a rational choice specifically for UTI.
Searcg
What antibiotic to use
| Loading dose | 300 mg colistin base activity (CBA) IV - single dose |
| Maintenance | 2.5-5 mg/kg/day CBA in 2-3 divided doses |
| Adjust for | Renal function (check creatinine first) |
| Duration | 10-14 days for complicated CA-UTI with pus |
Can I start Durataz for the time being
| Organism | Pip-Tazo Result |
|---|---|
| Citrobacter freundii | R |
| Acinetobacter baumannii complex | Likely R (consistent with XDR pattern) |